Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial (2017)
- Authors:
- Rosa, Priscila Raupp da
- Rohde, Luís Eduardo
- Doebber, Madeni
- Ribeiro, Antônio L. P.
- Prado, Deborah P.
- Bertoldi, Eduardo Gehling
- Figueiredo Neto, José Albuquerque de
- Köhler, Ilmar
- Beck-da-Silva, Luís
- Danzmann, Luiz Cláudio
- Moura, Lídia Zytynski
- Rover, Marciane
- Simões, Marcus Vinícius
- Sant'Anna, Roberto Tofani
- Biolo, Andréia
- Autor USP: SIMÕES, MARCUS VINÍCIUS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ahj.2017.08.012
- Subjects: BIOMARCADORES; INSUFICIÊNCIA CARDÍACA; PEPTÍDEO NATRIURÉTICO ATRIAL
- Language: Inglês
- Imprenta:
- Source:
- Título: American Heart Journal
- ISSN: 0002-8703
- Volume/Número/Paginação/Ano: v. 194, p. 125-131, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ROSA, Priscila Raupp da et al. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, v. 194, p. 125-131, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ahj.2017.08.012. Acesso em: 17 fev. 2026. -
APA
Rosa, P. R. da, Rohde, L. E., Doebber, M., Ribeiro, A. L. P., Prado, D. P., Bertoldi, E. G., et al. (2017). Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial. American Heart Journal, 194, 125-131. doi:10.1016/j.ahj.2017.08.012 -
NLM
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012 -
Vancouver
Rosa PR da, Rohde LE, Doebber M, Ribeiro ALP, Prado DP, Bertoldi EG, Figueiredo Neto JA de, Köhler I, Beck-da-Silva L, Danzmann LC, Moura LZ, Rover M, Simões MV, Sant'Anna RT, Biolo A. Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart failure: the ReBIC-1 trial [Internet]. American Heart Journal. 2017 ; 194 125-131.[citado 2026 fev. 17 ] Available from: https://doi.org/10.1016/j.ahj.2017.08.012 - Insuficiência cardíaca
- Diagnóstico, classificação a avaliação prognóstica da insuficiência cardíaca
- Insuficiência cardíaca
- Cintilografia de perfusão miocárdica
- Optimize Brazil: analysis of a multidisciplinary approach in a multicenter Brazilian cohort to optimize heart failure treatment
- Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: an in vitro evaluation
- Estudo cintilográfico da inervação simpática cardíaca, da perfusão miocárdica e do desempenho ventricular esquerdo na doença de chagas
- Insuficiência cardíaca
- Myocardial kinetics of reporter probe 'ANTPOT. 124 I'-FIAU in isolated perfused rat hearts after in vivo adenoviral transfer of herpes simplex virus type 1 thymidine kinase reporter gene
- The presence of left ventricular inotropic reserve correlates with improvement of left ventricular systolic function in non-ischemic cardiomyopathy patients after long-term oral administration of dypiridamole
Informações sobre o DOI: 10.1016/j.ahj.2017.08.012 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002916750.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
